Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

Adlai Nortye Ltd.

CIK 1944552 ANL·Pharmaceutical Preparations · All EDGAR filings ↗

Going concern Filing comparison

Adlai Nortye Ltd. no longer discloses a going-concern conclusion

Substantial doubt about ability to continue as a going concern No going-concern disclosure

As of December 31, 2025, the Group’s balance of cash and cash equivalents was $8,056 and the Group had net current liabilities of $14,736. These conditions indicate the existence of a material uncertainty that may cast significant doubt about the Group’s ability to continue as a going concern. Management has evaluated these conditions and has developed a plan to address the Company’s financial situation. The plan includes: In December 2025, the Company entered into an exclusive license agreement with Jiangsu Aosaikang Pharmaceutical Co., Ltd. (“ASK Pharm”) for the development and…
Evidence
Blank check
No
Comparable
Yes
Current state
none
Current state label
No going-concern disclosure
Direction
eased
Located in
going-concern note
Prior filed
2025-05-12
Prior form
20-F/A
Prior state
substantial_doubt
Prior state label
Substantial doubt about ability to continue as a going concern
Source
ASC 205-40 going-concern note comparison
Why
Disclosure about the company's ability to continue as a going concern changed compared with its previous report.